Oludare Ogunsola, DO
Sports Medicine · Chillicothe, OHNPI 1598911323
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (40.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by CDC Medical LLC at 57.1% of the total. Reporting peaked in 2019 at $856 and has fallen 75.6% since, to $209 in 2025.
Across 34 payments — averaging $61.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CDC Medical LLC$1K
- Arthrex$278
- Mimedx Group, Inc.$185
- Biocomposites Inc$77
- EMD Serono, Inc.$73
- Lilly USA, LLC$68
- plus $214 from 6 others
What the payments were for
- Travel & lodging$50324%
- Food & beverage$74836%
- Education$84040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CDC Medical LLC | 5 | $1,194 |
| Arthrex | 4 | $278 |
| Mimedx Group, Inc. | 1 | $185 |
| Biocomposites Inc | 1 | $77 |
| EMD Serono, Inc. | 5 | $73 |
| Lilly USA, LLC | 5 | $68 |
| Trice Medical, Inc. | 4 | $67 |
| Adamas Pharmaceuticals, Inc. | 3 | $38 |
| SK Life Science, Inc. | 2 | $34 |
| Pacira Therapeutics, Inc. | 2 | $33 |
| Bioventus LLC | 1 | $24 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
How this compares
$2,091 in reported general payments places this provider in the 60th percentile of 278 sports medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 92 | $3,221 |
| Gabapentin | 233 | $2,810 |
| Pregabalin | 64 | $1,414 |
| Prednisone | 85 | $797 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 97 | $637 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 55 | $633 |
| Meloxicam | 60 | $321 |
| Tramadol Hcl | 63 | $255 |
| Duloxetine Hcl | 16 | $253 |
| Diclofenac Sodium | 14 | $190 |
| Oxycodone Hcl | 24 | $176 |
| Amitriptyline Hcl | 11 | $160 |
| Baclofen | 11 | $78 |
| Methocarbamol | 12 | $66 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $60 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Chillicothe
- David FlaniganColumbus$915K
- Thomas EllisDublin$427K
- Paul SaluanCleveland$367K
- Vincent SammarcoCincinnati$361K
- Jovan LaskovskiAkron$337K
- Julie BishopColumbus$322K
- Dominic KingCleveland$233K
- Michael SalataCleveland$212K
- Jason GeninLorain$115K
- Christopher KaedingColumbus$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.